Hydrocodone Extended-Release Tablets and Sandostatin LAR Depot
Determining the interaction of Hydrocodone Extended-Release Tablets and Sandostatin LAR Depot and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hydrocodone
Brand name: Hysingla ER, Zohydro ER, Vantrela ER
Synonyms: Hydrocodone
Generic Name: octreotide
Brand name: Sandostatin, Sandostatin LAR Depot
Synonyms: Sandostatin LAR Depot (injection)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hydrocodone Extended-Release Tablets-Sandostatin LAR Depot injection
- Hydrocodone Extended-Release Tablets-Sani-Supp
- Hydrocodone Extended-Release Tablets-Sani-Supp rectal
- Hydrocodone Extended-Release Tablets-Sansert
- Hydrocodone Extended-Release Tablets-Santyl
- Hydrocodone Extended-Release Tablets-Saphris
- Sandostatin LAR Depot-Hydrocodone Polistirex and Chlorpheniramine Polistirex Suspension
- Sandostatin LAR Depot-Hydrocodone, Chlorpheniramine, and Pseudoephedrine
- Sandostatin LAR Depot-Hydrocodone, Pseudoephedrine, and Guaifenesin
- Sandostatin LAR Depot-Hydrocortisone
- Sandostatin LAR Depot-Hydrocortisone (Systemic)
- Sandostatin LAR Depot-Hydrocortisone 2.5%